NYT Science
US · 32 mins ago
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Do you trust NYT Science?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!